| Moderna Switzerland GmbH - Spikevax JN.1 (mRNA-1273.167), 0.10mg/ml, Dispersion zur Injektion | | 69788 | | 01 | | Spikevax JN.1 (mRNA-1273.167), 0.10mg/ml | | Dispersion zur Injektion | | J07BX | | Other Viral Vaccines | | 09.09.2024 | | |
| | Composition | | Suspension: SARS-CoV-2 JN.1 mRNA 50 µg pro dosi, heptadecan-9-ylis 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)-octanoas, cholesterolum, 1,2-distearoyl-sn-glycero-3-phosphocholinum, 1,2-dimyristoyl-rac-glycero-3-polyethylenglycoli 2000 aether methylicus, trometamolum, trometamoli hydrochloridum, acidum aceticum, natrii acetas trihydricus, saccharum, aqua ad iniectabile, pro dosi, natrium 0.017 mg pro dosi. | | Packungsbestandteile | | | | | | | | BAG: Active Agent | Dose |
|---|
| | 50 mcg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | 2000 | | | | | | | Acetic Acid | | | | | | | | Cholesterol | | | | | 50 µg | | | Sodium Acetate Trihydrate | | | | Sodium | 0.017 mg | | | | | | | | 1 | Suspension | | | | | | Trometamol | | |
| |
| |
|
